NDC 0093-8232 – Irbesartan and Hydrochlorothiazide

Irbesartan 300 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug 1 recall

Product NDC0093-8232

Product details

Brand name
Irbesartan and Hydrochlorothiazide
Generic name
Irbesartan and Hydrochlorothiazide
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA077369
Marketed since
August 27, 2013
Listing expires
December 31, 2027
Pharmacologic class
Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Active ingredients

Uses, dosage, side effects and warnings for Irbesartan and Hydrochlorothiazide →

Package NDC codes (2)

Package NDCDescriptionSince
0093-8232-5630 TABLET, FILM COATED in 1 BOTTLE (0093-8232-56)Aug 27, 2013
0093-8232-9890 TABLET, FILM COATED in 1 BOTTLE (0093-8232-98)Aug 27, 2013

Recalls mentioning this NDC

Other Irbesartan and Hydrochlorothiazide products